Condensed Consolidated Statement of Changes in Stockholders’ Equity - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income	Treasury Stock	Non-Controlling Interest
Beginning balance (in shares) at Mar. 31, 2024		38,709,000
Beginning balance at Mar. 31, 2024	$ 38,636,000	$ 387,000	$ 202,607,000	$ (154,796,000)	$ (985,000)	$ (8,682,000)	$ 105,000
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(22,337,000)		(25,000)	(22,312,000)
Net income attributable to non-controlling interest	13,000						13,000
Foreign currency translation adjustment	426,000				418,000		8,000
Issuance of restricted shares (in shares)		54,000
Issuance of restricted shares	0	$ 1,000	(1,000)
Shares issued for transaction bonus (in shares)		174,000
Shares issued for transaction bonus	889,000	$ 1,000	888,000
Shares issued in connection with MiX Combination (in shares)		70,704,000
Shares issued in connection with MiX Combination	362,005,000	$ 707,000	361,298,000
Acquired through MiX Combination	7,823,000		7,818,000				5,000
Shares withheld pursuant to vesting of restricted stock	(2,836,000)					(2,836,000)
Stock-based compensation	5,929,000		5,929,000
Ending balance (in shares) at Jun. 30, 2024		109,641,000
Ending balance at Jun. 30, 2024	390,548,000	$ 1,096,000	578,514,000	(177,108,000)	(567,000)	(11,518,000)	131,000
Beginning balance (in shares) at Mar. 31, 2024		38,709,000
Beginning balance at Mar. 31, 2024	38,636,000	$ 387,000	202,607,000	(154,796,000)	(985,000)	(8,682,000)	105,000
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(38,548,000)
Net income attributable to non-controlling interest	17,000
Ending balance (in shares) at Dec. 31, 2024		134,556,000
Ending balance at Dec. 31, 2024	458,541,000	$ 1,339,000	669,492,000	(193,345,000)	(7,578,000)	(11,518,000)	151,000
Beginning balance (in shares) at Jun. 30, 2024		109,641,000
Beginning balance at Jun. 30, 2024	390,548,000	$ 1,096,000	578,514,000	(177,108,000)	(567,000)	(11,518,000)	131,000
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(1,888,000)			(1,888,000)
Net income attributable to non-controlling interest	5,000						5,000
Foreign currency translation adjustment	(777,000)				(797,000)		20,000
Proceeds from private placement, net of costs to issue common stock	61,851,000		61,851,000
Exercise of stock options (in shares)		243,000
Stock-based compensation	1,371,000		1,371,000
Ending balance (in shares) at Sep. 30, 2024		109,884,000
Ending balance at Sep. 30, 2024	451,110,000	$ 1,096,000	641,736,000	(178,996,000)	(1,364,000)	(11,518,000)	156,000
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(14,349,000)			(14,349,000)
Net income attributable to non-controlling interest	(1,000)						(1,000)
Foreign currency translation adjustment	(6,218,000)				(6,214,000)		(4,000)
Proceeds from private placement, net of costs to issue common stock (in shares)		20,000,000
Proceeds from private placement, net of costs to issue common stock	4,608,000	$ 200,000	4,408,000
Shares issued in connection with MiX Combination (in shares)		4,286,000
Shares issued in connection with MiX Combination	21,343,000	$ 43,000	21,300,000
Exercise of stock options (in shares)		161,000
Exercise of stock options	910,000		910,000
Stock-based compensation	1,138,000		1,138,000
Issue of stock appreciation rights (in shares)		225,000
Ending balance (in shares) at Dec. 31, 2024		134,556,000
Ending balance at Dec. 31, 2024	$ 458,541,000	$ 1,339,000	669,492,000	(193,345,000)	(7,578,000)	(11,518,000)	151,000
Beginning balance (in shares) at Mar. 31, 2025	133,316,000	135,379,000
Beginning balance at Mar. 31, 2025	$ 446,742,000	$ 1,343,000	671,400,000	(205,783,000)	(8,850,000)	(11,518,000)	150,000
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(10,234,000)			(10,234,000)
Foreign currency translation adjustment	22,519,000				22,519,000
Stock-based compensation	1,853,000		1,853,000
Issue of stock appreciation rights (in shares)		127,000
Ending balance (in shares) at Jun. 30, 2025		135,506,000
Ending balance at Jun. 30, 2025	$ 460,880,000	$ 1,343,000	673,253,000	(216,017,000)	13,669,000	(11,518,000)	150,000
Beginning balance (in shares) at Mar. 31, 2025	133,316,000	135,379,000
Beginning balance at Mar. 31, 2025	$ 446,742,000	$ 1,343,000	671,400,000	(205,783,000)	(8,850,000)	(11,518,000)	150,000
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(17,886,000)
Net income attributable to non-controlling interest	$ 0
Ending balance (in shares) at Dec. 31, 2025	134,041,000	136,105,000
Ending balance at Dec. 31, 2025	$ 485,179,000	$ 1,343,000	677,377,000	(223,669,000)	41,496,000	(11,518,000)	150,000
Beginning balance (in shares) at Jun. 30, 2025		135,506,000
Beginning balance at Jun. 30, 2025	460,880,000	$ 1,343,000	673,253,000	(216,017,000)	13,669,000	(11,518,000)	150,000
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(4,288,000)			(4,288,000)
Foreign currency translation adjustment	9,793,000				9,793,000
Stock-based compensation	2,594,000		2,594,000
Issue of stock appreciation rights (in shares)		364,000
Ending balance (in shares) at Sep. 30, 2025		135,870,000
Ending balance at Sep. 30, 2025	468,979,000	$ 1,343,000	675,847,000	(220,305,000)	23,462,000	(11,518,000)	150,000
Increase (Decrease) in Stockholders' Equity
Net loss attributable to common stockholders	(3,364,000)			(3,364,000)
Net income attributable to non-controlling interest	0
Foreign currency translation adjustment	18,034,000				18,034,000
Exercise of stock options (in shares)		13,000
Exercise of stock options	39,000		39,000
Stock-based compensation	$ 1,491,000		1,491,000
Issue of stock appreciation rights (in shares)		222,000
Ending balance (in shares) at Dec. 31, 2025	134,041,000	136,105,000
Ending balance at Dec. 31, 2025	$ 485,179,000	$ 1,343,000	$ 677,377,000	$ (223,669,000)	$ 41,496,000	$ (11,518,000)	$ 150,000